www.actupny.org

 

Pharmaceutical Company Profits and Salaries
by Richard Laing, Department of International Health, School of Public Health,
Boston University, Presented @ Durban South Africa AIDS Conference 11 July 2000

 

1999 Pharmaceutical Company Reports

.
.
COMPANY

TOTAL
REVENUE
( in millions )

Cost of
Goods
( % revenue )

.
Market and
Administration

.
 R & D
( % revenue )

.
Profits

 

Merck

Novartis

BMS

Pfizer

Glaxo Wellcome

AHP

Abbott

Warner-Lambert

Smith Kline

Eli Lilly

Schering-Plough

Pharmacia

AMGEN

Genenteck

Biogen

 

$32,714

$32,465

$20,222

$14,133

$13,754

$13,550

$13,178

$12,929

$12,622

$10,003

$9,176

$7,253

$3,043

$1,039

$621

 

53.6 %

20.0 %

27.4 %

17.9 %

20.0 %

27.3 %

45.4 %

23.5 %

 

21.0 %

19.6 %

26.1 %

13.2 %

27.4 %

17.9 %

 

15.9 %

35.0 %

22.6 %

44.9 %

35.2 %

37.2 %

21.7 %

46.1 %

38.4 %

27.6 %

37.4 %

38.6 %

21.5 %

45.0 %

23.5 %

 

6.3 %

13.1 %

9.1 %

19.6 %

14.9 %

12.8 %

9.1 %

9.7 %

13.1 %

17.8 %

13.0 %

19.8 %

27.0 %

35.0 %

35.6 %

 

18.0 %

 

21.0 %

20.0 %

 

-9.0 %

19.0 %

13.0 %

 

27.0 %

23.0 %

11.0 %

33.0 %

Data from SEC 10K filings and 1999 Company Annual reports

 

1999 CEO Incomes

 

 

Charles A. Heimbold, Jr.
CEO, Bristol Myers Squibb
1999 Total Salary:
$39,752,611

 

 

 

Melvin R. Goodes
CEO, Warner-Lambertb
Unexercised stock options:
$204,680,776

 Name

 Company

 Salary *

 Total **

 Unexercised
Stock Options

 C.A. Heimbold, Jr.

W.C. Steere, Jr

R.V. Gilmartin

M.R. Goodes

R.J. Kogan

M.D. White

S. Taurel

J.R. Stafford

G.M. Binder

F. Hassan

BMS

Pfizer

Merck

Warn-Lam

Schering-Plough

Abbott

Lilly

AHP

AMGEN

Pharm & Upjohn

$31,424,000 

$15,159.000

$6,032,000

$16,486,000

$12,505,000

$4,381,000

$6,041,000

$4,093,000

$2,119,000

$2,366,000

 $39,753,000

$38,983,000

$26,424,000

$22,061,000

$18,525,000

$16,272,000

$12,940,000

$11,779,000

$6,385,000

$5,042,000

 $159,691,000

$107,115,000

$80,559,000

$250,681,000

 

$830,000

$33,667,000

$29,867,000

$104,506,000

$17,291,000

 * includes salary, bonus and other compensation
** Includes salary listed above with stock option grants
.

 Data from SEC filings and AFL-CIO websites
http://www.aflcio.org/cgi-bin/aflcio.pl
http://www.sec.gov

 


 

U.S. Pharmaceutical Market
1998 - 1999

Total pharmaceutical prescription sales: $107.1 billion:_ up 15.6% _(1998)

Promotional Spending:_$5.9 billion_(1998)

Leading Sellers:

Prilosec

Prozac

Augmentin

Cipro

Rocephin

Combivir

Viracept

Crixivan

$4.19 billion (99)

$2.57 billion (99)

$1.16 billion (99)

$921 million (99)

$517 million (99)

$465 million (99)

$448 million (99)

$223 million (99)

Sources: MM&M IMS America Business Watch May 1999 & Top 200 Drugs, Pharmacy Times April 2000

 

 

 



use back button on browser to return

 

see also:

HIGH DRUG PRICES LINKED TO ADVERTISING, PROFITS, AND ENORMOUS EXECUTIVE SALARIES

 

see also OFF-SITE WEBSITES:

Compulsory Licensing and Parallel Importing
What do they mean? Improving access to essential drugs for people living with HIV/AIDS
International Council of AIDS Service Organizations (ICASO)

 


MEDECINS SANS FRONTIERES

HIV/AIDS medicines pricing report
Setting objectives: Is there a political will?

 

back to >>> Durban Conference Report